Table 1.
The safety concerns and possible solutions for plasmid DNA vaccines and their production hosts. A priori each safety concern should be addressed as early in development as possible.
| Safety concern | Possible solution | |
| Genetic elements | Transfer of plasmid to host flora | Narrow host-range replication region Non-antibiotic plasmid marker |
| Germline integration | Avoidance of mammalian replication region | |
| Insertional mutagenesis and oncogenesis | Artificial DNA for promoter, intron, and signal sequence Avoidance of human-homologous DNA |
|
| Adverse effects of encoded peptide(s) | Artificial signal sequences Avoidance of mammalian replication region Evaluation of vaccine peptide case-by-case |
|
| Induction of autoimmune reactions | Minimized plasmids | |
| Production host | Endotoxins and biogenic amines | Use of gram-positive organism |
| Transferable antibiotic resistance genes | Determination of minimal inhibitory concentrations (MIC's) Screening for transferability |
|
| Genetic instability | Analysis of plasmid population by sequencing and mass spectrometry | |
| Pathogenicity | Use of food-grade organism | |